280E

State Regulators Struggle to Guide Cannabis Businesses on Schedule III

State marijuana regulators say they can't advise licensed businesses on rescheduling impacts because federal agencies haven't issued guidance on tax relief, banking, or compliance requirements.

May 31, 2026

Congress Urges IRS to Clarify Tax Rules for Cannabis Businesses

Congressional lawmakers are demanding the IRS provide immediate tax guidance for cannabis businesses following marijuana's rescheduling to Schedule III, which could end the industry's decades-long burden under Section 280E.

May 29, 2026

Federal Rescheduling Could Free $3B+ Locked in Cannabis Tax Penalties

DEA rescheduling would end IRS 280E tax penalties that forced cannabis companies into 70%+ effective tax rates, potentially unlocking $3B+ in sector-wide profits that were artificially suppressed for years.

May 25, 2026

Tariffs Could Wipe Out 280E Relief for Cannabis Cultivators

New analysis warns that Trump-era tariffs on imported cultivation equipment could offset tax savings from cannabis rescheduling, creating winners and losers across different license types.

May 22, 2026

Medical Cannabis Operators Rush to Register with DEA Post-Rescheduling

Medical cannabis operators are rushing to register with the DEA following marijuana rescheduling, hoping to secure 280E tax relief despite unclear federal guidance on whether registration will be mandatory.

May 14, 2026

DEA Portal Draws 400 Cannabis Operators in First Three Days

Nearly 400 cannabis businesses registered with the DEA's new portal in 72 hours, racing to meet a June 26 deadline for 280E tax relief under Schedule III rescheduling.

May 5, 2026

Cannabis Rescheduling Delivers Narrow 280E Tax Relief, Not Industry-Wide Win

Trump's marijuana rescheduling to Schedule III provides tax relief only for cultivation and manufacturing operations, while most dispensaries remain subject to Section 280E restrictions.

Apr 25, 2026

Trump Administration Moves Cannabis to Schedule III in Partial Win

The Trump administration rescheduled cannabis to Schedule III, providing tax relief to licensed operators but stopping short of full legalization. The move leaves banking restrictions and federal prohibition intact.

Apr 24, 2026

Cannabis Operators Pivot Strategy as Schedule III Decision Looms

Cannabis companies are pursuing clinical trial partnerships and expansion strategies in anticipation of marijuana's potential rescheduling to Schedule III, even as the DEA's final decision timeline remains uncertain.

Apr 24, 2026

IRS to Issue Tax Guidance as Schedule III Takes Effect for Medical Cannabis

Treasury officials will issue new tax guidance following the Trump administration's order moving state-licensed medical marijuana to Schedule III, potentially ending 280E tax penalties for qualifying businesses.

Apr 24, 2026

Legal Cannabis Companies Paid $2.24B in Extra Taxes Under 280E in 2025

Legal cannabis operators paid $2.24 billion in excess federal taxes in 2025 due to Section 280E, with some facing effective rates near 70%, according to Whitney Economics analysis.

Apr 18, 2026

Trump Advisor Says Internal Resistance Stalling Cannabis Rescheduling

A Trump advisor reveals internal administration resistance is delaying marijuana rescheduling three months after the president's executive order, creating uncertainty for cannabis businesses awaiting tax relief.

Apr 10, 2026

Rescheduling Won't Fix Cannabis Industry Without Insurance Access

Cannabis industry experts argue Trump's rescheduling order won't stabilize the market without insurance reimbursement access, which matters more than tax relief for long-term viability.

Mar 4, 2026